Biostar Pharmaceuticals, Inc. Announces 2012 First Quarter Financial Results
XIANYANG, China, May 15, 2012 /PRNewswire-Asia/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced its financial res...
Biostar Pharmaceuticals to Announce 2012 First Quarter Financial Results and Conduct Conference Call on Tuesday, May 15th
XIANYANG, China, May 9, 2012 /PRNewswire-Asia/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced that it will issue...
Biostar Pharmaceuticals, Inc. To Supply All Hospitals In Three Chinese Provinces With Huangyangning Tablets
XIANYANG, China, April 23, 2012 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced that ...
Biostar Pharmaceuticals, Inc. Regains Compliance with NASDAQ's Minimum Bid Price Requirement
XIANYANG, China, April 20, 2012 /PRNewswire-Asia/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced that it has rec...
Biostar Pharmaceuticals to Effect Reverse Stock Split
XIANYANG, China, April 3, 2012 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based developer, manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today annou...
Biostar Pharmaceuticals, Inc. Announces 2011 Fourth Quarter And Year-end Financial Results
XIANYANG, China, March 27, 2012 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced its f...
Biostar Pharmaceuticals To Announce 2011 Fourth Quarter and Year-end Results and Conduct Conference Call on Tuesday, March 27th
XIANYANG, China, March 23, 2012 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced that ...
Biostar Pharmaceuticals Selected by the FMMU to Cooperate in the Fields of Research and Product Development
XIANYANG, China, Jan. 23, 2012 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a developer, manufacturer and marketer of pharmaceutical and health supplement products for a variety of diseases and conditions, today announced that on Januar...
Biostar Pharmaceuticals, Inc. Announces 2011 Third Quarter Financial Results
XIANYANG, China, Nov. 14, 2011 /PRNewswire-Asia-FirstCall/ -- *Biostar Pharmaceuticals, Inc.* (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a developer, manufacturer and marketer of pharmaceutical and health supplement products for a variety of diseases and conditions, today announced its financia...
Biostar Pharmaceuticals to Announce 2011 Third Quarter Results On Monday, November 14th and Conduct Conference Call on Tuesday, November 15th
XIANYANG, China, Nov. 10, 2011 /PRNewswire-Asia-FirstCall/ -- *Biostar Pharmaceuticals, Inc.* (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a developer, manufacturer and marketer of pharmaceutical and health supplement products for a variety of diseases and conditions, today announced that it will...
Biostar Pharmaceuticals' CEO to Join World Leaders at the APEC 2011 CEO Summit on November 11 - 12, 2011 in Hawaii
XIANYANG, China, Nov. 7, 2011 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a developer, manufacturer and marketer of pharmaceutical and health supplement products for a variety of diseases and conditions, today announced that its Chairm...
Biostar Pharmaceuticals Acquires Shaanxi Weinan Huaren Pharmaceuticals, Ltd.
XIANYANG, China, Oct. 25, 2011 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a developer, manufacturer and marketer of pharmaceutical and health supplement products for a variety of diseases and conditions, today announced that on Octobe...
Biostar Pharmaceuticals Signs Agreement to Acquire Shaanxi Weinan Huaren Pharmaceuticals, Ltd.
XIANYANG, China, Oct. 11, 2011 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a developer, manufacturer and marketer of pharmaceutical and health supplement products for a variety of diseases and conditions, today announced that its wholl...
Biostar Pharmaceuticals, Inc. to Attend Rodman & Renshaw Annual Global Investment Conference
XIANYANG, China, Sept. 1, 2011 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a Xianyang-based manufacturer of a leading PRC over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules and a variety of pharmaceutical product...
Biostar Pharmaceuticals, Inc. Announces Second Quarter and First Half 2011 Unaudited Financial Results
XIANYANG, China, Aug. 15, 2011 /PRNewswire-Asia-FirstCall/ -- BioStar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("BioStar" or "the Company"), a Xianyang-based manufacturer of a leading PRC over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules ("Xin Aoxing") and a variety of pharmac...
BioStar Pharmaceuticals, Inc. Schedules Second Quarter 2011 Earnings Release on August 15, 2011
XIANYANG, China, Aug. 8, 2011 /PRNewswire-Asia/ -- BioStar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("BioStar" or "the Company"), a Xianyang-based manufacturer of a leading PRC over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules and a variety of pharmaceutical products, today an...
BioStar Pharmaceuticals, Inc. to Attend 2011 Global Hunter Securities Conference
XIANYANG, China, July 13, 2011 /PRNewswire-Asia-FirstCall/ -- BioStar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("BioStar" or "the Company"), a Xianyang-based manufacturer of a leading PRC over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules and a variety of pharmaceutical product...
BioStar Pharmaceuticals, Inc. to Attend Brean Murray, Carret & Co. 2011 Beijing China Growth Conference
XIANYANG, China, June 21, 2011 /PRNewswire-Asia-FirstCall/ -- BioStar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("BioStar" or "the Company"), a Xianyang-based manufacturer of a leading PRC over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules and a variety of pharmaceutical product...
BioStar Pharmaceuticals, Inc. Appoints Fleishman-Hillard as its Investor Relations Agency and Provides Update on Share Repurchase Program
XIANYANG, China, June 13, 2011 /PRNewswire-Asia/ -- BioStar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("BioStar" or "the Company"), a Xianyang-based manufacturer of a leading PRC over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules and a variety of pharmaceutical products, today a...
Chairman and CEO of Biostar Pharmaceuticals, Inc. Adopts 10b5-1 Share Repurchase Plan
XIANYANG, China, May 25, 2011 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM), Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules ("Xin Aoxing Capsules"), and a variety of pharmaceutical products, today an...
